WASHINGTON—U.S. Senators Chris Murphy (D-CT) and Richard Blumenthal (D-CT) sent a letter to Federal Bureau of Prisons (BOP) Director Michael Carvajal seeking an explanation for BOP’s failed response to the spread of COVID-19 at FCI Danbury. The letter follows a Senate Judiciary Committee hearing “Examining Best Practices for Incarceration and Detention During COVID-19,” during which Blumenthal questioned Carvajal on BOP’s response to the COVID-19 outbreak at FCI Danbury. As of June 5, 2020, 98 inmates and 61 staff members at FCI Danbury have tested positive and one inmate has died.
“In your testimony, you repeatedly told Senator Blumenthal that you would “get” or “look into” the information that you did not know then. Sadly, BOP provided minimal additional information following your testimony, and failed to seriously address any of Senator Blumenthal’s questions,” wrote the senators.
This is the third letter Murphy and Blumenthal have sent to Carvajal regarding the COVID-19 response at FCI Danbury. Letters sent on April 13, 2020 and May 1, 2020 expressed significant concerns that FCI Danbury will continue to be a hotspot for COVID-19, putting inmates, staff, and the greater community at risk.
“Serving time or working inside a prison should not be a sentence to sickness or death. Your failure to answer questions both during the hearing and afterwards calls into question whether BOP is taking appropriate measures to protect inmates and correctional officers from this disease. That is why we are writing once again to seek a response to these important questions,” the senators continued.
The letter to Director Carvajal can be found here and below.
Dear Director Carvajal:
On Tuesday, June 2, 2020, you testified before the Senate Committee on the Judiciary during a hearing entitled, “Examining Best Practices for Incarceration and Detention During COVID-19.” We were disappointed that you were unable to answer Senator Blumenthal’s fundamental questions about the Bureau of Prison’s (BOP) response to the COVID-19 outbreak at FCI Danbury during that hearing. Serving time or working inside a prison should not be a sentence to sickness or death. Your failure to answer questions both during the hearing and afterwards calls into question whether BOP is taking appropriate measures to protect inmates and correctional officers from this disease. That is why we are writing once again to seek a response to these important questions.
The Committee hearing was intended to address, in part, BOP’s response to the ongoing public health crisis caused by COVID-19. That crisis has not spared FCI Danbury, which Attorney General Barr, in his April 3, 2020 memorandum, specifically identified as a BOP facility “experiencing significant levels of infection.”[1] As of June 5, 2020, 98 inmates and 61 staff members at FCI Danbury have tested positive and one inmate has died.[2]
In letters that we sent to you on April 13, 2020 and May 1, 2020, we expressed our concerns that FCI Danbury will continue to be a hotspot for COVID-19, putting inmates, staff, and the greater community at risk. While you did not officially respond to these letters, we had hoped that your testimony before the Committee would address these concerns. Unfortunately, it did not.
During the Committee hearing, Senator Blumenthal asked specific questions about FCI Danbury, and in particular, BOP’s compliance with a temporary restraining order (TRO) issued by the District Court for the District of Connecticut in Dianthe Martinez Brooks et al. v. D. Easter & Michael Carvajal on May 12,[3] including:
In your testimony, you repeatedly told Senator Blumenthal that you would “get” or “look into” the information that you did not know then. Sadly, BOP provided minimal additional information following your testimony, and failed to seriously address any of Senator Blumenthal’s questions. BOP stated that 314 “medically vulnerable” inmates had been reviewed per the TRO and that FCI Danbury had reviewed “about 351 inmates for home confinement placement” and “released 191 inmates.”[7] BOP also responded that “the issue raised by . . . Senator [Blumenthal] is a matter pending litigation, as such as we cannot comment on the matter.”[8]
On June 3, Chairman Graham noted that, at the June 2 hearing, “[T]here were a lot of questions asked about COVID-19 and prisons,” and that he expected, “those will get answered—particularly, Senator Blumenthal’s questions about the [TRO].”[9] We expect the same, and respectfully request that you respond to the following questions:
Thank you for your timely attention to this matter. We look forward to hearing your response no later than June 18, 2020.
Sincerely,
###